Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 227–227 | Cite as

Ruxolitinib

Various infections following off-label use: 6 case reports
Case report
  • 8 Downloads

Reference

  1. Modi B, et al. Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 25: 265-269, No. 2, Feb 2019. Available from: URL: http://doi.org/10.1016/j.bbmt.2018.09.003 - USACrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations